梓橦宫：在研产品取得药品注册申请受理通知书
Sichuan Zitonggong Pharmaceuticals Sichuan Zitonggong Pharmaceuticals (BJ:832566) Zheng Quan Ri Bao·2025-08-29 14:04

Core Points - The company, Zizhong Temple, announced that it has received the acceptance notice from the National Medical Products Administration for its product, Glucosamine Sulfate Capsules, which is currently under research [2] Group 1 - The acceptance notice indicates that the company's application for domestic production and drug registration for Glucosamine Sulfate Capsules has been officially accepted [2]